Tucows Inc. (LON:0LH4)

Marinus Pharmaceuticals Revenue

Tucows had revenue of $94.61M USD in the quarter ending March 31, 2025, with 8.18% growth. This brings the company's revenue in the last twelve months to $369.43M, up 6.66% year-over-year. In the year 2024, Tucows had annual revenue of $362.28M with 6.76% growth.

• Revenue (ttm): $369.43M
• Revenue Growth: +6.66%
• P/S Ratio: 0.48
• Revenue / Employee: $482.91K
• Employees: 765
• Market Cap: 137.82M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	362.28M	22.94M	6.76%
Dec 31, 2023	339.34M	18.20M	5.67%
Dec 31, 2022	321.14M	16.81M	5.52%
Dec 31, 2021	304.34M	-6.87M	-2.21%
Dec 31, 2020	311.20M	-25.94M	-7.69%